1)Amsterdam JD, Shults J:Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode:a randomized open-label study. J Clin Psychopharmacol 28:171-181, 2008
2)Amsterdam JD, Shults J:Efficacy and mood conversion rate of short-term fluoxetine monotherapy of bipolar II major depressive episode. J Clin Psychopharmacol 30:306-311, 2010
3)Amsterdam JD, Shults J:Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder:a randomized, double-blind, placebo-substitution study. Am J Psychiatry 167:792-800, 2010
4)Amsterdam JD, Lorenzo-Luaces L, Soeller I, et al:Short-term venlafaxine v. lithium monotherapy for bipolar type II major depressive episodes:effectiveness and mood conversion rate. Br J Psychiatry 208:359-365, 2016
5)Ashman SB, Monk TH, Kupfer DJ, et al:Relationship between social rhythms and mood in patients with rapid cycling bipolar disorder. Psychiatry Res 86:1-8, 1999
6)Benazzi F:Is there a continuity between bipolar and depressive disorders? Psychother Psychosom 76:70-76, 2007
7)Berk M, Dodd S:Bipolar II disorder:a review. Bipolar Disord 7:11-21, 2005
8)Boker SM, Leibenluft E, Deboeck PR, et al:Mood Oscillations and Coupling Between Mood and Weather in Patients with Rapid Cycling Bipolar Disorder. Int J Child Health Hum Dev 1:181-203, 2008
9)Bond DJ, Noronha MM, Kauer-Sant' Anna M, et al:Antidepressant-associated mood elevations in bipolar II disorder compared with bipolar I disorder and major depressive disorder:a systematic review and meta-analysis. J Clin Psychiatry 69:1589-1601, 2008
10)Bradley AJ, Webb-Mitchell R, Hazu A, et al:Sleep and circadian rhythm disturbance in bipolar disorder. Psychol Med 47:1678-1689, 2017
11)Brietzke E, Moreira CL, Duarte SV, et al:Impact of comorbid migraine on the clinical course of bipolar disorder. Compr Psychiatry 53:809-812, 2012
12)Calabrese JR, Suppes T, Bowden CL, et al:A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group. J Clin Psychiatry 61:841-850, 2000
13)Calabrese JR, Keck PE Jr., Macfadden W, et al:A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry 162:1351-1360, 2005
14)Calabrese JR, Huffman RF, White RL, et al:Lamotrigine in the acute treatment of bipolar depression:results of five double-blind, placebo-controlled clinical trials. Bipolar Disord 10:323-333, 2008
15)Camacho EM, Ntais D, Jones S, et al:Cost-effectiveness of structured group psychoeducation versus unstructured group support for bipolar disorder:Results from a multi-centre pragmatic randomised controlled trial. J Affect Disord 211:27-36, 2017
16)Cerullo MA, Strakowski SM:The prevalence and significance of substance use disorders in bipolar type I and II disorder. Subst Abuse Treat Prev Policy 2:29, 2007
17)Chiang KJ, Tsai JC, Liu D, et al:Efficacy of cognitive-behavioral therapy in patients with bipolar disorder:A meta-analysis of randomized controlled trials. PLoS One 12:e0176849, 2017
18)Dunner DL, Gershon ES, Goodwin FK:Heritable factors in the severity of affective illness. Biol Psychiatry 11:31-42, 1976
19)Frye MA, Ketter TA, Kimbrell TA, et al:A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol 20:607-614, 2000
20)Geddes JR, Calabrese JR., Goodwin GM:Lamotrigine for treatment of bipolar depression:independent meta-analysis and meta-regression of individual patient data from five randomised trials. Br J Psychiatry 194:4-9, 2009
21)Ghaemi SN, Ko JY, Goodwin FK:” Cade's disease” and beyond:misdiagnosis, antidepressant use, and a proposed definition for bipolar spectrum disorder. Can J Psychiatry 47:125-134, 2002
22)Ghaemi SN, Gilmer WS, Goldberg JF, et al:Divalproex in the treatment of acute bipolar depression:a preliminary double-blind, randomized, placebo-controlled pilot study. J Clin Psychiatry 68:1840-1844, 2007
23)Gumus F, Buzlu S, Cakir S:Effectiveness of individual psychoeducation on recurrence in bipolar disorder:a controlled study. Arch Psychiatr Nurs 29:174-179, 2015
24)Iglesias-Gonzalez M, Aznar-Lou I, Gil-Girbau M, et al:Comparing watchful waiting with antidepressants for the management of subclinical depression symptoms to mild-moderate depression in primary care:a systematic review. Fam Pract 34:639-648, 2017
25)Judd LL, Akiskal HS, Schettler PJ, et al:A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry 60:261-269, 2003
26)Katagiri H, Tohen M, McDonnell DP, et al:Efficacy and safety of olanzapine for treatment of patients with bipolar depression:Japanese subpopulation analysis of a randomized, double-blind, placebo-controlled study. BMC Psychiatry 13:138, 2013
27)MacQueen GM, Young LT:Bipolar II disorder:symptoms, course, and response to treatment. Psychiatr Serv 52:358-361, 2001
28)McElroy SL, Weisler RH, Chang W, et al:A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression(EMBOLDEN II). J Clin Psychiatry 71:163-174, 2010
29)日本うつ病学会気分障害の治療ガイドライン作成委員会:日本うつ病学会治療ガイドラインⅡ.うつ病(DSM-5)/大うつ病性障害.2016
30)日本うつ病学会気分障害の治療ガイドライン作成委員会:日本うつ病学会治療ガイドラインⅠ.双極性障害.2017
31)Parikh SV, Hawke LD, Velyvis V, et al:Combined treatment:impact of optimal psychotherapy and medication in bipolar disorder. Bipolar Disord 17:86-96, 2015
32)Perlis RH, Ostacher MJ, Patel JK, et al:Predictors of recurrence in bipolar disorder:primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder(STEP-BD). Am J Psychiatry 163:217-224, 2006
33)Proudfoot J, Whitton A, Parker G, et al:Triggers of mania and depression in young adults with bipolar disorder. J Affect Disord 143:196-202, 2012
34)佐藤純:天気痛—つらい痛み・不安の原因と治療方法.光文社,2017
35)Scharer LO, Hartweg V, Hoern M, et al:Electronic diary for bipolar patients. Neuropsychobiology 46(Suppl 1):10-12, 2002
36)Scharer LO, Krienke UJ, Graf SM, et al:Validation of life-charts documented with the personal life-chart app-a self-monitoring tool for bipolar disorder. BMC Psychiatry 15:49, 2015
37)Suppes T, Marangell LB, Bernstein IH, et al:A single blind comparison of lithium and lamotrigine for the treatment of bipolar II depression. J Affect Disord 111:334-343, 2008
38)Svendal G, Fasmer OB, Engeland A, et al:Co-prescription of medication for bipolar disorder and diabetes mellitus:a nationwide population-based study with focus on gender differences. BMC Med 10:148, 2012
39)Swartz HA, Thase ME:Pharmacotherapy for the treatment of acute bipolar II depression:current evidence. J Clin Psychiatry 72:356-366, 2011
40)Swartz HA, Levenson JC, Frank E:Psychotherapy for Bipolar II Disorder:The Role of Interpersonal and Social Rhythm Therapy. Prof Psychol Res Pr 43:145-153, 2012
41)Thase ME, Macfadden W, Weisler RH, et al:Efficacy of quetiapine monotherapy in bipolar I and II depression:a double-blind, placebo-controlled study(the BOLDER II study). J Clin Psychopharmacol 26:600-609, 2006
42)van der Loos ML, Mulder PG, Hartong EG, et al:Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression:a multicenter, double-blind, placebo-controlled trial. J Clin Psychiatry 70:223-231, 2009
43)Wong MM:Management of Bipolar II Disorder. Indian J Psychol Med 33:18-28, 2011
44)Young AH, McElroy SL, Bauer M, et al:A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression(EMBOLDEN I). J Clin Psychiatry 71:150-162, 2010
45)Young AH, McElroy SL, Olausson B, et al:A randomised, placebo-controlled 52-week trial of continued quetiapine treatment in recently depressed patients with bipolar I and bipolar II disorder. World J Biol Psychiatry 15:96-112, 2014